ATOSSA THERAPEUTICS, INC. — Director's Dealing 2012

Nov 7, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ATOSSA GENETICS INC (ATOS)
CIK: 0001488039
Period of Report: 2012-11-07

Reporting Person: CROSS ALEXANDER D (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	88366	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$6.00	2022-04-30	Common Stock (5927)		Direct
Stock Option (Right to Buy)	$1.25	2021-09-01	Common Stock (40000)		Direct

Footnotes

F1: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the Reporting Person is the beneficial owner of all of the reported shares for purposes of Section 16 or for any other purpose.

F2: On April 30, 2012, the Board of Directors approved a grant to the Reporting Person of stock options to purchase an aggregate of 5,927 shares of Common Stock, fully vested and exercisable as of the date of grant.

F3: The first 10,000 options vested on December 1, 2011 and the remaining options vested in equal quarterly amounts on each of March 1, 2012, June 1, 2012 and September 1, 2012.